Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Desmopressin 5micrograms/5ml oral solution
0605020E0AABSBS
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1 |
|
Dexamethasone 1.5mg/ml eye dps 0.3ml ud preservative free
1104010I0AAAXAX
|
Dexamethasone (Eye) | Dexamethasone | Eye | 1 |
|
Dextromethorphan 7.5mg/5ml / Menthol 2.5mg/5ml oral solution
0309010L0AAAVAV
|
Dextromethorphan hydrobromide | Dextromethorphan hydrobromide | Respiratory System | 1 |
|
Dialyvit tablets
091200000BFWRFT
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | 1 |
|
Diamorphine 5mg powder for solution for injection vials
0407020K0AAEFEF
|
Diamorphine hydrochloride (Systemic) | Diamorphine hydrochloride (Systemic) | Central Nervous System | 1 |
|
Diamox Sodium Parenteral 500mg inj vials
1106000C0BBAAAA
|
Diamox (Parenteral) | Acetazolamide sodium | Eye | 1 |
|
Diazoxide 10mg/5ml oral liquid
0601040E0AAAXAX
|
Diazoxide (Systemic) | Diazoxide | Endocrine System | 1 |
|
Diazoxide 25mg/5ml oral liquid
0601040E0AAAQAQ
|
Diazoxide (Systemic) | Diazoxide | Endocrine System | 1 |
|
Dicloflex 50mg gastro-resistant tablets (Dexcel-Pharma)
1001010C0BQABAE
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1 |
|
Dicloflex 75mg SR tablets (Almus)
1001010C0BQALAL
|
Dicloflex | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1 |
|
Dimethyl sulfoxide 50% cream
100302040AAAAAA
|
Dimethyl sulfoxide (Topical) | Dimethyl sulfoxide | Musculoskeletal and Joint Diseases | 1 |
|
Discreet sheath tacky 25mm
22306153064
|
Discreet sheath tacky 25mm | Incontinence Sheaths | Incontinence Appliances | 1 |
|
Disulfiram 500mg tablets
0410010B0AAAEAE
|
Disulfiram | Disulfiram | Central Nervous System | 1 |
|
Dithranol 0.1% in Zinc and Salicylic acid paste
1305020F0AAETET
|
Dithranol (Topical) | Dithranol | Skin | 1 |
|
Dithranol 0.5% in Zinc and Salicylic acid paste
1305020F0AAFAFA
|
Dithranol (Topical) | Dithranol | Skin | 1 |
|
Dovonex 50micrograms/g cream
1305020D0BBABAB
|
Dovonex | Calcipotriol | Skin | 1 |
|
Doxycycline 100mg/5ml oral suspension
0501030I0AAAKAK
|
Doxycycline hyclate (Antibacterial) | Doxycycline hyclate | Infections | 1 |
|
Doxylar 100mg capsules
0501030I0BCAAAB
|
Doxylar | Doxycycline hyclate | Infections | 1 |
|
Draina S Vision 75 wound drainage bag
20031500066
|
Draina S Vision 75 wound drainage bag | Wound Management & Other Dressings | Dressings | 1 |
|
Drainable night drainage bag 2litre (WM 71)
22605306000
|
Drainable night drainage bag 2litre (WM 71) | Night Drainage Bags | Incontinence Appliances | 1 |
|
Drainage bag connecting tube with three way stopcock 30cm
22806208018
|
Drainage bag connecting tube with three way stopcock 30cm | Tubing And Accessories | Incontinence Appliances | 1 |
|
Drainage bag connecting tube with three way stopcock/funnel 6cm
22806208010
|
Drainage bag connecting tube with three way stopcock/funnel 6cm | Tubing And Accessories | Incontinence Appliances | 1 |
|
Drawtex dressing 5cm x 5cm
20031700157
|
Drawtex dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | 1 |
|
DreamSkin baby leggings with foldaway feet 3-6 months
20200000308
|
DreamSkin baby leggings with foldaway feet 3-6 months | Silk Garments | Dressings | 1 |
|
DreamSkin baby leggings with foldaway feet 6-9 months
20200000161
|
DreamSkin baby leggings with foldaway feet 6-9 months | Silk Garments | Dressings | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.